JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 27, 2005; DOI: 10.1124/jpet.105.091868


0022-3565/06/3161-71-78$20.00
JPET 316:71-78, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.091868v1
316/1/71    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, L.
Right arrow Articles by Ramkumar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, L.
Right arrow Articles by Ramkumar, V.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-{alpha} Release by Reducing Calcium-Dependent Activation of Nuclear Factor-{kappa}B and Extracellular Signal-Regulated Kinase 1/2

Lynn Martin, Sandeep C. Pingle, Daniel M. Hallam, Leonard P. Rybak, and Vickram Ramkumar

Departments of Pharmacology (L.M., S.C.P., D.M.H., L.P.R., V.R.) and Surgery (L.P.R.), Southern Illinois University School of Medicine, Springfield, Illinois

Bacterial lipopolysaccharide (LPS) activates the immune system and promotes inflammation via Toll-like receptor (TLR) 4, which regulates the synthesis and release of tumor necrosis factor (TNF)-{alpha} and other inflammatory cytokines. Previous studies have shown that the nucleoside adenosine suppresses LPS-stimulated TNF-{alpha} release in human UB939 macrophages by activating an adenosine A3 receptor (A3AR) subtype on these cells. In this study, we examined the mechanism(s) underlying A3AR-dependent inhibition of TNF-{alpha} release in a mouse (RAW 264.7) cell line. Treatment of RAW 264.7 cells with LPS (3 µg/ml) increased TNF-{alpha} release, which was reduced in a dose-dependent manner by adenosine analogs N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA) and R-phenylisopropyladenosine and reversed by selective A3AR blockade. The increase in TNF-{alpha} release was preceded by an increase in intracellular Ca2+ levels. Inhibition of intracellular Ca2+ release by IB-MECA, a selective agonist of the A3AR, or with BAPTA-AM, an intracellular Ca2+ chelator, reduced LPS-stimulated TNF-{alpha} release. Activation of the A3AR or inhibition of intracellular Ca2+ release also reduced LPS-stimulated nuclear factor-{kappa}B (NF-{kappa}B) activation and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. Similar inhibition by A3AR was observed for LPS-stimulated inducible nitric-oxide synthase. These data support the contention that inhibition of LPS-stimulated release of inflammatory molecules, such as TNF-{alpha} and NO via the A3AR, involves suppression of intracellular Ca2+signaling, leading to suppression of NF-{kappa}B and ERK1/2 pathways.


Received for publication July 1, 2005
Accepted September 26, 2005.

Address correspondence to: Dr. Vickram Ramkumar, Dept. of Pharmacology, Southern Illinois University School of Medicine, P.O. Box 19230, Springfield, IL 62794-1222. E-mail: vramkumar{at}siumed.edu




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. E. Barnholt, R. S. Kota, H. H. Aung, and J. C. Rutledge
Adenosine Blocks IFN-{gamma}-Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation
J. Immunol., November 15, 2009; 183(10): 6767 - 6777.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Liu, M. Yao, N. Li, C. Wang, Y. Zheng, and X. Cao
CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages
Blood, December 15, 2008; 112(13): 4961 - 4970.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. Morschl, J. G. Molina, J. B. Volmer, A. Mohsenin, R. S. Pero, J.-S. Hong, F. Kheradmand, J. J. Lee, and M. R. Blackburn
A3 Adenosine Receptor Signaling Influences Pulmonary Inflammation and Fibrosis
Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 697 - 705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo
Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals
J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman
Purinergic receptors in gastrointestinal inflammation
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Pingle, S. Jajoo, D. Mukherjea, L. F. Sniderhan, K. A. Jhaveri, A. Marcuzzi, L. P. Rybak, S. B. Maggirwar, and V. Ramkumar
Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-Induced Apoptosis by Reducing Nuclear Factor-{kappa}B Activation and Inducible Nitric-Oxide Synthase
Mol. Pharmacol., October 1, 2007; 72(4): 856 - 867.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.